Clinical trial
Prospective Clinical Trial Evaluating the Safety and Efficacy of Prosthetic Polymer Heart Valves for the Treatment of Aortic Valve Disease
NCT06518681 is registered in ClinicalTrials.gov with Suzhou Hearthill Medical Technology Co.,LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Clinical Trial Evaluating the Safety and Efficacy of Prosthetic Polymer Heart Valves for the Treatment of Aortic Valve Disease
- Lead sponsor
- Suzhou Hearthill Medical Technology Co.,LTD
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- August 15, 2024
- Completion date
- December 30, 2025
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic valve disease, aortic valve regurgitation, aortic valve stenosis